U.S. Congress - H.R.4332 Generic Drug Application Review Fairness Act of 2012
H.R.4332 - Generic Drug Application Review Fairness Act of 2012
To amend section 505(j) of the Federal Food, Drug, and Cosmetic Act to extend the period for a first applicant, with respect to a generic drug, to obtain tentative approval without forfeiting the 180-day exclusivity period, and for other purposes. view all titles (2)
All Bill Titles
- Official: To amend section 505(j) of the Federal Food, Drug, and Cosmetic Act to extend the period for a first applicant, with respect to a generic drug, to obtain tentative approval without forfeiting the 180-day exclusivity period, and for other purposes. as introduced.
- Short: Generic Drug Application Review Fairness Act of 2012 as introduced.
This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it.
| All Actions | |
|---|---|
| Mar 29th | Referred to the House Committee on Energy and Commerce. |
| Mar 29th | Introduced in House |
| Mar 30th | Referred to the Subcommittee on Health. |
| Apr 30th | Referred to the Subcommittee on Health. |
Vote on This Bill
-
Share This Bill
More Share via Email
